Momenta Pharmaceuticals to Webcast Presentation at the UBS 2015 Global Healthcare Conference
May 12 2015 - 4:00PM
Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology
company specializing in the characterization and engineering of
complex drugs, today announced that its presentation at the UBS
2015 Global Healthcare Conference will be webcast on Tuesday, May
19, 2015 at 4:30 p.m. ET.
The audio webcast of the presentation will be available live on
the "Investors" section of the company's website located at
www.momentapharma.com. A replay of the presentation will be posted
on the Momenta website approximately one hour after the event and
will be available for two weeks following the presentation.
About Momenta Momenta Pharmaceuticals is a
biotechnology company specializing in the detailed structural
analysis of complex drugs and is headquartered in Cambridge, MA.
Momenta is applying its technology to the development of generic
versions of complex drugs, biosimilar and potentially
interchangeable biologics, and to the discovery and development of
novel therapeutics for oncology and autoimmune indications.
To receive additional information about Momenta, please visit
the website at www.momentapharma.com, which does not form a part of
this press release.
Our logo, trademarks, and service marks are the property of
Momenta Pharmaceuticals, Inc. All other trade names, trademarks, or
service marks are property of their respective owners.
CONTACT: Sarah Carmody
Momenta Pharmaceuticals
1-617-395-5189
IR@momentapharma.com
Momenta Pharmaceuticals (NASDAQ:MNTA)
Historical Stock Chart
From Mar 2024 to Apr 2024
Momenta Pharmaceuticals (NASDAQ:MNTA)
Historical Stock Chart
From Apr 2023 to Apr 2024